Chiron Real Estate (XRN) Q1 2025 earnings summary

Executive summary

• Net income attributable to common shareholders rose to $2.1 million ($0.03/share) in Q1 2025, up from $0.8 million ($0.01/share) year-over-year, driven by gains on property sales and lower G&A expenses.

• Portfolio occupancy was 95.6% with a weighted average lease term of 5.6 years and rent coverage ratio of 4.4x as of March 31, 2025.

• Completed $69.6 million acquisition of a five-property medical portfolio, adding 486,598 sq ft and $6.3 million annualized base rent at a 9% cap rate; three properties closed in Q1, two in April.

• Disposed of two medical facilities for $8.2 million, realizing a $1.4 million gain; one facility was vacant at sale.

• CEO succession plan is underway, with transition expected by June 30, 2025; current CEO will become Chairman.

Financial highlights

• Total revenues for Q1 2025 were $34.6 million, down 1.4% year-over-year, primarily due to property dispositions.

• FFO and AFFO per share/unit were $0.20 and $0.22, both down $0.01 from the prior year quarter.

• G&A expenses decreased to $3.6 million from $4.4 million, mainly due to lower non-cash LTIP compensation.

• Interest expense increased to $7.2 million from $6.9 million year-over-year due to higher average borrowings.

• Dividends per share remained at $0.21; preferred dividends paid totaled $1.5 million.

Outlook and guidance

• Reaffirmed full-year 2025 AFFO per share/unit guidance of $0.89–$0.93, excluding one-time CEO succession expenses.

• Guidance assumes no additional acquisitions/dispositions or equity/debt issuances beyond those already announced.

• Management expects continued acquisition activity, with two additional properties acquired in April 2025 for $38.1 million.

• Unutilized borrowing capacity under the credit facility was $187 million as of May 6, 2025.

• No shares were issued under the ATM program in Q1 2025 or through May 6, 2025.